These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7507155)

  • 41. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
    Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract]   [Full Text] [Related]  

  • 42. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2.
    Rebollo A; Mérida I; Gómez J; Pitton C; Silva A; Martínez C; García A
    Cytokine; 1995 Apr; 7(3):277-86. PubMed ID: 7543780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative effects of rapamycin, FK 506 and cyclosporine on antibody production, lymphocyte populations and immunoglobulin isotype switching in the rat.
    Thomson AW; Propper DJ; Woo J; Whiting PH; Milton JI; Macleod AM
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):355-69. PubMed ID: 7693791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice.
    Nagai H; Hiyama H; Matsuo A; Ueda Y; Inagaki N; Kawada K
    J Pharmacol Exp Ther; 1997 Oct; 283(1):321-7. PubMed ID: 9336339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition by rapamycin of ornithine decarboxylase and epithelial cell proliferation in intestinal IEC-6 cells in culture.
    Seidel ER; Ragan VL
    Br J Pharmacol; 1997 Feb; 120(4):571-4. PubMed ID: 9051292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of cyclosporin A and FK 506 on the cAMP content in psoriatic keratinocytes.
    Ockenfels HM; Nussbaum G; Schneck B; Wagner SN; Haen E; Goos M
    Skin Pharmacol; 1996; 9(4):281-8. PubMed ID: 8896120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
    Gregory CR; Pratt RE; Huie P; Shorthouse R; Dzau VJ; Billingham ME; Morris RE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):770-1. PubMed ID: 7679842
    [No Abstract]   [Full Text] [Related]  

  • 48. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
    Nakajima H; Oka T
    Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
    [No Abstract]   [Full Text] [Related]  

  • 49. FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0/G1 phases of the cell cycle.
    Karashima T; Hachisuka H; Sasai Y
    J Dermatol Sci; 1996 Sep; 12(3):246-54. PubMed ID: 8884530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat.
    Yoshimura R; Yoshimura N; Ohmachi T; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T
    Transplant Proc; 1994 Oct; 26(5):2890. PubMed ID: 7524223
    [No Abstract]   [Full Text] [Related]  

  • 51. Evidence that rapamycin has differential effects of IL-4 function. Multiple IL-4 signaling pathways and implications for in vivo use.
    Taylor-Fishwick DA; Kahan M; Hiestand P; Ritter MA; Foxwell BM
    Transplantation; 1993 Aug; 56(2):368-74. PubMed ID: 7689258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of cyclosporin A and FK506 on proliferation and IL-8 production of cultured human keratinocytes.
    Kaplan A; Matsue H; Shibaki A; Kawashima T; Kobayashi H; Ohkawara A
    J Dermatol Sci; 1995 Sep; 10(2):130-8. PubMed ID: 8534611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Siekierka JJ; Lin CS; Harrison R; Sewell T; Kindt VM; Beattie TR; Wyvratt M
    J Exp Med; 1992 Sep; 176(3):751-60. PubMed ID: 1380976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclosporine, FK-506 and other drugs in organ transplantation.
    Morris PJ
    Curr Opin Immunol; 1991 Oct; 3(5):748-51. PubMed ID: 1721824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of transcription factor NF kappa B in Jurkat cells is inhibited selectively by FK 506 in a signal-dependent manner.
    Su MS; Semerjian A
    Transplant Proc; 1991 Dec; 23(6):2912-5. PubMed ID: 1721310
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of FK-506, rapamycin, ascomycin, and cyclosporine in mouse models of host-versus-graft disease and heterotopic heart transplantation.
    Mollison KW; Fey TA; Krause RA; Thomas VA; Mehta AP; Luly JR
    Ann N Y Acad Sci; 1993 Jun; 685():55-7. PubMed ID: 7689812
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibition by rapamycin of leukocyte migration and bronchial hyperreactivity induced by injection of Sephadex beads to guinea-pigs.
    Nogueira de Francischi J; Conroy DM; Maghni K; Sirois P
    Br J Pharmacol; 1993 Dec; 110(4):1381-6. PubMed ID: 7508325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases?
    Meingassner JG; Stütz A
    J Invest Dermatol; 1992 Jun; 98(6):851-5. PubMed ID: 1375617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of cyclosporin A, rapamycin, and FK520 on peripheral T-cell deletion and anergy.
    Prud'homme GJ; Vanier LE; Bocarro DC; Ste-Croix H
    Cell Immunol; 1995 Aug; 164(1):47-56. PubMed ID: 7543371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
    de Paulis A; Ciccarelli A; Marinò I; de Crescenzo G; Marinò D; Marone G
    Arthritis Rheum; 1997 Mar; 40(3):469-78. PubMed ID: 9082935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.